Toronto general hospital controlled trial data plasma exchange therapy in guillain-barre' syndrome
✍ Scribed by Kenneth H. Shumak; John G. Humphrey; Joseph Y. Chiu; Margaret L. Routledge; Marilyn Elphick; Hope E. Humphrey
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 336 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
✦ Synopsis
The mechanism by which plasma exchange (PE) may benefit patients with acute Gillain-Barrel syndrome (AGBS) is unclear. It is possible, therefore, that the response of patients with AGBS is influenced by the choice of replacement solution (whole plasma vs. albumin or similar protein-containing solution). This report compares the outcome in 57 patients with AGBS treated at the Toronto General Hospital (TGH) using conventional therapy (271, PE with plasma replacement (15) and PE with albumin replacement (15). Fifteen patients (5 treated conventionally, 8 by PE with plasma replacement, 2 by PE with albumin